MTOR and melanoma: mTOR inhibition can also enhance the maintenance and self-renewal of various stem cell types (reviewed in [269]), and the relapse of advanced melanomas is believed to rely, at least in part, on “dormant” de-differentiated cancer cells with stem cell-like features.